Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13

Pharmacology and Therapeutics

Volumn 88, Issue 2, 2000, Pages 143-151

  McKenzie, Andrew N J ^a  

^a MRC LABORATORY OF MOLECULAR BIOLOGY   (United Kingdom)

Author keywords

Asthma; Fibrosis; Helminths; Interleukin 13; Interleukin 4; Th2 immunity

Indexed keywords

CYTOKINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; INTERLEUKIN RECEPTOR; STAT PROTEIN;

ALLERGY; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOKINE RESPONSIVE ELEMENT; ENDOTOXEMIA; HELMINTHIASIS; IMMUNE RESPONSE; INFLAMMATION; LIVER FIBROSIS; LUNG GRANULOMA; NONHUMAN; PRIORITY JOURNAL; SCHISTOSOMIASIS; TH2 CELL;

EID: 0034522650     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(00)00088-7     Document Type: Review

References (72)

1. cDNA cloning and characterisation of the human interleukin-13 receptor α chain
2. Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses
3. Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice
4. Genetic susceptibility to Leishmania infections: Studies in mice and men
5. Eosinophilic inflammation in asthma
6. Activated mast cells produce interleukin-13
7. Cloning and characterisation of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor α chain
8. An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response
9. IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs
10. Mechanism and regulation of immunoglobulin isotype switching
11. IL-13 in allergy: Home at last
12. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that controls susceptibility to infection by Leishmania major
13. Effects of IL-13 on phenotype, cytokine production and cytotoxic function of human monocytes
14. Modulation of murine macrophage function by IL-13
15. The murine IL-13 receptor alpha 2: Molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1
16. Interleukin (IL)-4-independent induction of immunoglobulin (Ig)E, and perturbation of T-cell development in transgenic mice expressing IL-13
17. Schistosome infection of transgenic mice defines distinct and contrasting roles for IL-4 and IL-13: IL-13 is a profibrotic agent
18. Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody
19. Cytokine regulation of host defence against parasitic gastrointestinal nematodes: Lessons from studies with rodent models
20. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster
21. Requirement for IL-13 independently of IL-4 in experimental asthma
22. Cloning and characterisation of a binding subunit of the interleukin-13 receptor that is also a component of the interleukin-4 receptor
23. Schistosome-infected IL-4 receptor knockout (KO) mice, in contrast to IL-4 KO mice, fail to develop granulomatous pathology while maintaining the same lymphokine expression profile
24. STAT6 is required for mediating responses to IL-4 and for the development of Th2 cells
25. Th2 cells are required for the Schistosoma mansoni egg-induced granulomatous response
26. Similarities and differences in signal transduction by interleukin-4 and interleukin-13: Analysis of Janus kinase activation
27. Reduced amount of intestinal mucus by treatment with anti-CD4 antibody interferes with the spontaneous cure of Nippostrongylus brasiliensis infection in mice
28. Disruption of the murine IL-4 gene blocks Th2 cytokine responses
29. Generation and analysis of interleukin-4-deficient mice
30. Mouse IL-13 enhances antibody production in vivo and acts directly on B-cells in vitro to increase survival and hence antibody production
31. Nippostrongylus brasiliensis: Cytokine responses and nematode expulsion in normal and IL-4-deficient mice
32. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection
33. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13 and IL-5
34. + T-cells
35. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
36. IL-13 is a susceptibility factor for leishmania major infection
37. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function
38. Structural comparison and chromosomal location of the human and mouse IL-13 genes
39. A distinct role for interleukin-13 in Th2 cell-mediated immune responses
40. Impaired development of Th2 cells in IL-13-deficient mice
41. Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses
42. The granulomatous response in Schistosomiasis mansoni does not switch to Th1 in IL-4-deficient C57BL/6 mice
43. Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex
44. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses
45. Differences between IL-4-and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling
46. Interleukin (IL)-4-independent immunoglobulin class switch to immunoglobulin (Ig)E in the mouse
47. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties
48. Selective effector mechanisms for the expulsion of intestinal helminths
49. IL-4-and IL-4 receptor-deficient BALB/c mice reveal differences in susceptibility to Leishmania major parasite substrains
50. Receptor for interleukin 13: Interaction with interleukin-4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9 and 15
51. IL-10 synergises with IL-4 and transforming growth factor-β to inhibit macrophage cytotoxic activity
52. Schistosoma mansoni in IL-4-deficient mice
53. Interleukin-13 induces interleukin-4-independent IgG4 and IgE synthesis and CD23 expression by human B-cells
54. The regulation of immunity to Leishmania major
55. + T cells during initiation of infection
56. Cure of leishmaniasis with anti-interleukin 4 monoclonal antibody
57. IL-5, eosinophils, and disease
58. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted STAT6 gene
59. A family of cytokine-inducible inhibitors of signalling
60. Essential role of STAT6 in IL-4 signalling
61. Interleukin-4 treatment can cure established gastrointestinal nematode infections in immunocompetent and immunodeficient mice
62. IL-13, IL-4Ralpha, and STAT6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis
63. The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice
64. Granuloma formation around Schistosoma mansoni, S. haematobium, and S. japonicum eggs
65. Interleukin-13: Central mediator of allergic asthma
66. Cytokine-induced apoptosis in epithelial HT-29 cells is independent of nitric oxide formation. Evidence for an interleukin-13-driven phosphatidylinositol 3-kinase-dependent survival mechanism
67. Analysis of cytokine mRNA expression during primary granuloma formation induced by eggs of Schistosoma mansoni
68. Isolation and characterisation of a human interleukin cDNA clone, homologous to B-cell stimulatory factor 1, that expresses B-cell- and T-cell-stimulating activities
69. Identification, purification and characterisation of a soluble interleukin (IL)-13-binding protein. Evidence that it is distinct from the cloned IL-13 receptor and IL-4 receptor alpha chains
70. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
71. Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B-cells but not on T-cells
72. Receptors for interleukin-13 and interleukin-4 are complex share a novel component that functions in signal transduction